Yi GZ - Search Results

1

The Impact of MMP-2 and Its Specific Inhibitor TIMP-2 Expression on the WHO Grade and Prognosis of Gliomas in Chinese Population: a Meta-Analysis.

Yi GZ, Feng WY, Zhou Q, Liu YW, Qi ST. Yi GZ, et al. Mol Neurobiol. 2017 Jan;54(1):22-30. doi: 10.1007/s12035-015-9539-x. Epub 2016 Jan 4. Mol Neurobiol. 2017. PMID: 26729052 Free PMC article.

2

[RNA interference of PC4 and SFRS1 interacting protein 1 inhibits invasion and migration of U87 glioma cells].

Xiang W, Qi ST, Liu YW, Li HZ, Zhou Q, Yi GZ, Chen ZY, Yan L. Xiang W, et al. Among authors: yi gz. Nan Fang Yi Ke Da Xue Xue Bao. 2016 Jun;36(6):802-6. Nan Fang Yi Ke Da Xue Xue Bao. 2016. PMID: 27320882 Chinese.

3

Akt and β-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line.

Yi GZ, Liu YW, Xiang W, Wang H, Chen ZY, Xie SD, Qi ST. Yi GZ, et al. J Neurol Sci. 2016 Aug 15;367:101-6. doi: 10.1016/j.jns.2016.05.054. Epub 2016 Jun 1. J Neurol Sci. 2016. PMID: 27423571

4

Overexpression of COX7A2 is associated with a good prognosis in patients with glioma.

Deng S, Li Y, Yi G, Lei B, Guo M, Xiang W, Chen Z, Liu Y, Qi S. Deng S, et al. J Neurooncol. 2018 Jan;136(1):41-50. doi: 10.1007/s11060-017-2637-z. Epub 2017 Oct 27. J Neurooncol. 2018. PMID: 29079956

5

Antitumor Activity and Mechanism of a Reverse Transcriptase Inhibitor, Dapivirine, in Glioblastoma.

Liu W, Song XL, Zhao SC, He M, Wang H, Chen Z, Xiang W, Yi G, Qi S, Liu Y. Liu W, et al. J Cancer. 2018 Jan 1;9(1):117-128. doi: 10.7150/jca.21965. eCollection 2018. J Cancer. 2018. PMID: 29290776 Free PMC article.

6

Identification of Key Candidate Proteins and Pathways Associated with Temozolomide Resistance in Glioblastoma Based on Subcellular Proteomics and Bioinformatical Analysis.

Yi GZ, Xiang W, Feng WY, Chen ZY, Li YM, Deng SZ, Guo ML, Zhao L, Sun XG, He MY, Qi ST, Liu YW. Yi GZ, et al. Biomed Res Int. 2018 Mar 1;2018:5238760. doi: 10.1155/2018/5238760. eCollection 2018. Biomed Res Int. 2018. PMID: 29687002 Free PMC article.

7

miR-1268a regulates ABCC1 expression to mediate temozolomide resistance in glioblastoma.

Li Y, Liu Y, Ren J, Deng S, Yi G, Guo M, Shu S, Zhao L, Peng Y, Qi S. Li Y, et al. J Neurooncol. 2018 Jul;138(3):499-508. doi: 10.1007/s11060-018-2835-3. Epub 2018 Jun 6. J Neurooncol. 2018. PMID: 29876787

8

Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2.

Yi GZ, Huang G, Guo M, Zhang X, Wang H, Deng S, Li Y, Xiang W, Chen Z, Pan J, Li Z, Yu L, Lei B, Liu Y, Qi S. Yi GZ, et al. Brain. 2019 Aug 1;142(8):2352-2366. doi: 10.1093/brain/awz202. Brain. 2019. PMID: 31347685 Free PMC article.

9

The combination of two-dimensional and three-dimensional analysis methods contributes to the understanding of glioblastoma spatial heterogeneity.

Yang R, Guo J, Lin Z, Song H, Feng Z, Ou Y, Zhou M, Li Y, Yi G, Li K, Li K, Guo M, Wang X, Huang G, Liu Z, Qi S, Liu Y. Yang R, et al. J Biophotonics. 2020 Feb;13(2):e201900196. doi: 10.1002/jbio.201900196. Epub 2019 Dec 4. J Biophotonics. 2020. PMID: 31743584

10

Quantitative Proteomics Analysis Reveals Nuclear Perturbation in Human Glioma U87 Cells treated with Temozolomide.

Guo J, Yi GZ, Liu Z, Sun X, Yang R, Guo M, Li Y, Li K, Li K, Wang X, Song H, Qi S, Huang G, Liu Y. Guo J, et al. Among authors: yi gz. Cell Biochem Funct. 2020 Mar;38(2):185-194. doi: 10.1002/cbf.3459. Epub 2019 Dec 12. Cell Biochem Funct. 2020. PMID: 31833081

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters